Noninvasive vascular function measurement in the community: cross-sectional relations and comparison of methods Circ Cardiovasc Imaging 2011;4:371–380 282 Hamburg NM, Palmisano J, Larson MG, et al Relation of brachial and digital measures of vascular function in the community: the framingham heart study Hypertension 2011;57:390–396 283 Selamet Tierney ES, Newburger JW, Gauvreau K, et al Endothelial pulse amplitude testing: feasibility and reproducibility in adolescents J Pediatr 2009;154:901–905 284 Flammer AJ, Anderson T, Celermajer DS, et al The assessment of endothelial function: from research into clinical practice Circulation 2012;126:753–767 285 Huang AL, Silver AE, Shvenke E, et al Predictive value of reactive hyperemia for cardiovascular events in patients with peripheral arterial disease undergoing vascular surgery Arterioscler Thromb Vasc Biol 2007;27:2113– 2119 286 Anderson TJ, Charbonneau F, Title LM, et al Microvascular function predicts cardiovascular events in primary prevention: long-term results from the firefighters and their endothelium (FATE) study Circulation 2011;123:163–169 287 Heiss C, Lauer T, Dejam A, et al Plasma nitroso compounds are decreased in patients with endothelial dysfunction J Am Coll Cardiol 2006;47:573–579 288 Rassaf T, Heiss C, Hendgen-Cotta U, et al Plasma nitrite reserve and endothelial function in the human forearm circulation Free Radic Biol Med 2006;41:295–301 289 Lauer T, Preik M, Rassaf T, et al Plasma nitrite rather than nitrate reflects regional endothelial nitric oxide synthase activity but lacks intrinsic vasodilator action Proc Natl Acad Sci USA 2001;98:12814–12819 290 Heiss C, Dejam A, Kleinbongard P, et al Vascular effects of cocoa rich in flavan-3-ols JAMA 2003;290:1030–1031 291 Vallance P, Lieper J Cardiovascular biology of the asymmetric dimethylarginine: dimethylarginine dimethylaminohydrolase pathway Arterioscler Thromb Vasc Biol 2004;24:1023–1030 292 Böger RH, Maas R, Schulze F, et al Elevated levels of asymmetric dimethylarginine (ADMA) as a marker of cardiovascular disease and mortality Clin Chem Lab Med 2005;43:1124– 1129 293 Ley K, Tedder TF Leukocyte interactions with vascular endothelium: new insights into selectinmediated attachment and rolling J Immunol 1995;155:525–528 294 Rueckschloss U, Duerrschmidt N, Morawietz H NADPH oxidase in endothelial cells: impact on atherosclerosis Antioxid Redox Signal 2003;5:171–180 295 Vaughan DE PAL-1 and atherothrombosis Thromb Haemost 2005;3:1879–1883 296 Mannucci PM Von willebrand factor: a marker of endothelial damage? Arterioscler Thromb Vasc Biol 1998;18:1359–1362 297 Brown NJ, Gainer JV, Murphey LJ, et al Bradykinin stimulates tissue plasminogen activator release from human forearm vasculature through B(2) receptor-dependent, NO synthase-independent and cyclo-oxygenaseindependent pathway Circulation 2000;102:2190–2196 298 Hrafnkelsdottir T, Wall U, Jern C, et al Impaired capacity for endogenous fibrinolysis in essential hypertension Lancet 1998;352:1597–1598 299 Newby DE, Mcleod AL, Uren NG, et al Impaired coronary tissue plasminogen activator release is associated with coronary atherosclerosis and cigarette smoking: direct link ... Mannucci PM Von willebrand factor: a marker of endothelial damage? Arterioscler Thromb Vasc Biol 1998; 18:1359–1362 297 Brown NJ, Gainer JV, Murphey LJ, et al Bradykinin stimulates tissue plasminogen... Hrafnkelsdottir T, Wall U, Jern C, et al Impaired capacity for endogenous fibrinolysis in essential hypertension Lancet 1998; 352:1597–1598 299 Newby DE, Mcleod AL, Uren NG, et al Impaired coronary tissue plasminogen activator